Premium
PRELIMINARY RESULTS OF EARLIER STEROID USE WITH AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA
Author(s) -
Topp M.S.,
Van Meerten T.,
Wermke M.,
Lugtenburg P.J.,
Minnema M.C.,
Song K.W.,
Thieblemont C.,
Jiang Y.,
Plaks V.,
Kerber A.,
Kersten M.J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.114_2630
Subject(s) - medicine , cytokine release syndrome , refractory (planetary science) , adverse effect , cohort , lymphoma , gastroenterology , clinical endpoint , hematopoietic stem cell transplantation , transplantation , surgery , chimeric antigen receptor , cancer , randomized controlled trial , immunotherapy , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom